openPR Logo
Press release

Ophthalmic Drugs Market Expected to Reach $42,663 Million, Globally by 2023

10-11-2018 05:22 PM CET | Health & Medicine

Press release from: Allied Market Research

Ophthalmic Drugs Market Expected to Reach $42,663 Million,

According to a new report published by Allied Market Research, titled, "Ophthalmic Drugs Market by Indication, Type, Distribution Channel, Dosage Form, Technology, and Therapeutic Class: Global Opportunity Analysis and Industry Forecast, 2017-2023", the global ophthalmic drugs market was valued at $29,613 million in 2016, and is projected to reach $42,663 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. The retinal disorders segment accounted for 26.6% of the global ophthalmic drugs market in 2016.

The development of effective ophthalmic is crucial is the current scenario, owing to increase in incidence of ophthalmic disorders such as glaucoma, cataract, and other common eye infections. Ophthalmic drugs are administered in different dosage forms depending upon the indication. Market players focus on innovation of novel approaches for the development of ophthalmic drugs over the years, including small molecule, biologics, and recombinant technologies, thereby driving the growth of ophthalmic drugs market.

Request sample copy of this report @ https://www.alliedmarketresearch.com/request-sample/310

Increase in focus towards developing combination therapies for treatment of ophthalmic disorders, prevalence of these disorders, and surge in geriatric population are projected to drive the ophthalmic drugs market growth. In addition, continuous change in demographics worldwide supplements this growth. However, longer timelines required for the approval of novel ophthalmic drugs and side effects associated with the same limit market expansion.

Conversely, surge in investment by manufacturers in the emerging economies and rise in initiatives to reduce the burden of glaucoma globally are anticipated to offer lucrative opportunities for market expansion. The multicompartment drug delivery systems is expected to witness a CAGR of 8.0% from 2017 to 2023, as these systems are ideal to sustain and deliver therapeutics to the target tissues and cells. The anti-inflammatory segment accounted for 28% of ophthalmic drugs market share in 2016, and is projected to continue its dominance throughout the forecast period.

Among distribution channel, hospital pharmacies generated the highest revenue in 2016, accounting for 31% of the total ophthalmic drugs market share, and are anticipated to continue this trend throughout the forecast period. Moreover, online pharmacies segment is expected to witness a high growth rate of 5.8%, owing to increase in trend of online ordering and easy availability of drugs.

Key Findings of the Ophthalmic Drugs Market:
• The liquid ophthalmic drug forms generated the highest revenue in 2016, and are anticipated to continue the same trend, registering a CAGR of 4.1% from 2017 to 2023.
• The cell therapy technologies registered significant growth rate and is expected to register a CAGR of 6.5%.
• North America dominated the market, accounting for maximum share of 36% of the total market in 2016 and is expected to witness a CAGR of 4.4%.
• The online pharmacies segment is witnessing the highest CAGR of 5.8% among the end users.
• Anti-inflammatory drugs accounted for two-sevenths share of the global ophthalmic drugs market in 2016.
• Asia-Pacific is expected to witness highest growth rate for ophthalmic drugs throughout the forecast period, and is expected to continue this trend, owing to high population density, increase in geriatric population, and rise in incidence of congenital glaucoma and cataract in India and China.

The key players operating in the ophthalmic drugs market have adopted product launch as one of their key developmental strategies, among others such as business expansion, product development, and business acquisition. The major companies profiled in the report include Santen Pharmaceutical Co., Ltd., Bausch & Lomb Inc. (Valeant Pharmaceuticals International, Inc.), Shire Plc, Alcon (Novartis), Genentech, Inc. Allergan, Plc, Sun Pharmaceutical Industries Limited, Actavis Generics (Teva Pharmaceutical Industries Ltd.), Regeneron Pharmaceuticals, Inc., and Pfizer Inc.

Check offers and discount on this report @ https://www.alliedmarketresearch.com/get-discount/310

About Us:
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ophthalmic Drugs Market Expected to Reach $42,663 Million, Globally by 2023 here

News-ID: 1297789 • Views:

More Releases from Allied Market Research

Future of Recycled Plastic: Emerging Technologies and Market Projections, A Comprehensive Analysis by 2032
Future of Recycled Plastic: Emerging Technologies and Market Projections, A Comp …
According to the report recently published by Allied Market Research, the global recycled plastic market size was generated $66.7 billion in 2022, and is anticipated to generate $141.9 billion by 2032, witnessing a CAGR of 7.9% from 2023 to 2032. Increasing awareness about environmental issues such as plastic pollution and ocean trash and garbage, as well as rising greenhouse gas emissions are expected to drive the growth of the global
Exploring Opportunities in the Application Container Market | Current Trends, Growth, Segmentation and In-depth Analysis of Industry Players
Exploring Opportunities in the Application Container Market | Current Trends, Gr …
According to a recent report published by Allied Market Research, the global application container market was valued at $698 million in 2016, and is projected to reach at $8,202 million by 2025, growing at a CAGR of 31.8% from 2018 to 2025. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4693 The application container market refers to the industry surrounding the development, deployment, and management of application containers, which are lightweight, standalone, executable software packages that
On Grid String Inverter Market: Global Opportunity Analysis and Industry Forecast, 2021-2031
On Grid String Inverter Market: Global Opportunity Analysis and Industry Forecas …
Allied Market Research published an exclusive report, titled, "On Grid String Inverter Market Size, Share, Competitive Landscape and Trend Analysis Report by Phase, by End-Use Industry : Global Opportunity Analysis and Industry Forecast, 2021-2031". The global on grid string inverter market was valued at $1.9 billion in 2021, and is projected to reach $3.7 billion by 2031, growing at a CAGR of 6.9% from 2022 to 2031. Download Research Report Sample &
Private security market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.8%, surpassing $531.5 billion by 2032.
Private security market is projected to grow at a Compound Annual Growth Rate (C …
According to a new report published by Allied Market Research, titled, "Private Security Market," The private security market size was valued at $241.4 billion in 2022, and is estimated to reach $531.5 billion by 2032, growing at a CAGR of 7.8% from 2023 to 2032. Private security services are the execution of safety precautions and safeguarding by non-governmental organizations or individuals to protect person, property, and assets. These services include a

All 5 Releases


More Releases for Ophthalmic

Ophthalmic Trial Frames Market Depth Survey Report 2019| Topcon, Luneau, Takagi …
Ophthalmic trial frames are adjustable frames that are used to hold lenses during refraction test and during retinoscopy test of the eye. Ophthalmic trial frames are eyeglasses designed in such a way that different lenses can be inserted and can be used to correct refractive errors of vision. Ophthalmic trial frames are light weight, adjustable and should have a comfortable nose resting and can be adjusted to allow accurate centering.
Ophthalmic Eye Shield Market Segmentation By Material type Aluminium Ophthalmic …
Eye shields are advised for use in the eye while a periorbital surgery to avoid any injury to the globe. Ophthalmic eye shields are used for postoperative ocular protection. Ophthalmic eye shields protect the cornea and retina while any eye surgery or laser treatment. Ophthalmic eye shields are highly preferred for cataract surgeries in the elder population and blepharitis correction especially for children. According to WHO, The World Health Organization,
04-08-2019 | Health & Medicine
Fact.MR
Eye socket Implants Market Offered in New Research Forecasted through 2026 // Ke …
The global Eye socket Implants market is expected to see remarkable growth in the forecast period due to increase in work-related eye injuries. Increase in the number of patients drives the overall eye socket implants market. Higher adoption of surgeries in higher economic regions propels the Eye socket Implants Market. Others factors like increasing prevalence and incidence of eye-related disease, changing lifestyle pattern are the factors which are fueling the
Ophthalmic Surgical Technologies Market - Femtosecond Systems Likely to Dominate …
The global ophthalmic surgical technologies market is driven mainly by the growing funding in the healthcare sector and the rising awareness about eye care, added to the rising prevalence of eye diseases. The ophthalmic surgical technologies market has enjoyed a supportive regulatory and economic structure in most regions in the recent past and is thus likely to continue on the strong growth trajectory it has exhibited in recent years. Increasing
Ophthalmic Lasers Market: Demand for Ophthalmic Lasers to Remain Higher in North …
Lasers have become an essential part of treatment modality for a number of practicing ophthalmologist. Ophthalmic lasers have gained prominence with the popularity of laser-assisted surgeries for rectifying nearsightedness or myopia. The increasing incidence of ophthalmic disorders and rise in geriatric population in various regions have boosted the application of different types of lasers in treating specific eye problems and improving vision. Technological advances have significantly increased the safety and
Ophthalmic Ultrasound Device Market: A-scan Ophthalmic Ultrasound Devices High i …
Global Ophthalmic Ultrasound Device Market: Snapshot The constantly increasing percentage of the geriatric population across the world is widely considered as the primary factor augmenting the demand for ophthalmic ultrasound devices. The high geriatric population is directly linked to the increasing patient count for ocular diseases and disorders, along with chronic diseases such as diabetes. The increasing levels of pollution are also responsible for the high volume of ovular disorders across